Please Note - Streaming News is only available to subscribers to the Active Level and above
Director Deals - (GSK)
BFN
Hal Barron, Executive Director, has re-invested 180 shares in the company on the 24th February 2022 at a price of $20.60. The Director now holds 921,161 shares.
Story provided by StockMarketWire.com
Director deals data provided by www.sharesmagazine.co.uk
